Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Franck Touret and Magali Gilles.
Franck Touret
Connection Strength
0.868
Magali Gilles
  1. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Res. 2021 09; 193:105137.
    View in: PubMed
    Score: 0.239
  2. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium. mBio. 2021 08 31; 12(4):e0085021.
    View in: PubMed
    Score: 0.239
  3. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci Rep. 2020 08 04; 10(1):13093.
    View in: PubMed
    Score: 0.224
  4. Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics? Viruses. 2020 07 07; 12(7).
    View in: PubMed
    Score: 0.056
  5. Prolonged Infectivity of SARS-CoV-2 in Fomites. Emerg Infect Dis. 2020 09; 26(9).
    View in: PubMed
    Score: 0.056
  6. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples. Viruses. 2020 06 08; 12(6).
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.